Thereafter, Yoon et al. could not only confirm the association of GATA3 IHC positivity with better BC-related survival in a consecutive series of 242 BCs and in the ER-positive subgroup, but also found it in low-grade groups [17]. The gene discussed is GATA3; the disease is breast cancer.